Ftse Mib
33.235,42
-0,24%
DAX
18.067,91
-0,31%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
65.095,49
-0,07%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Skye Bioscience Inc (QB) (SKYE) Skye Bioscience Inc (QB) (SKYE) Notizie

SKYE

Skye Bioscience (QB) (SKYE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:SKYE
DataOraFonteTitoloSimboloCompagnia
05/03/202401:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
04/03/202422:23Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SKYESkye Bioscience Inc (QB)
04/03/202422:18Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
04/03/202412:15Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]USOTC:SKYESkye Bioscience Inc (QB)
12/02/202418:08Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:SKYESkye Bioscience Inc (QB)
31/01/202422:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:SKYESkye Bioscience Inc (QB)
03/10/202322:12Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:SKYESkye Bioscience Inc (QB)
28/08/202322:16Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipUSOTC:SKYESkye Bioscience Inc (QB)
07/08/202322:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:SKYESkye Bioscience Inc (QB)
31/03/202322:35Edgar (US Regulatory)Annual Report (10-k)USOTC:SKYESkye Bioscience Inc (QB)
27/03/202322:10Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:SKYESkye Bioscience Inc (QB)
20/03/202311:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:SKYESkye Bioscience Inc (QB)
17/03/202319:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SKYESkye Bioscience Inc (QB)
23/02/202323:22Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SKYESkye Bioscience Inc (QB)
16/02/202323:38Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:SKYESkye Bioscience Inc (QB)
09/01/202317:28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:SKYESkye Bioscience Inc (QB)
20/12/202213:31InvestorsHub NewsWireSkye Bioscience Receives FDA Authorization of Investigational New Drug Application for SBI-100 OEUSOTC:SKYESkye Bioscience Inc (QB)
16/12/202213:57InvestorsHub NewsWireSkye Bioscience Doses First Cohort of Participants in Phase 1 Clinical Trial of SBI-100 Ophthalmic EmulsionUSOTC:SKYESkye Bioscience Inc (QB)
15/11/202221:47Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)USOTC:SKYESkye Bioscience Inc (QB)
14/11/202221:20Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SKYESkye Bioscience Inc (QB)
01/09/202222:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:SKYESkye Bioscience Inc (QB)
31/01/202219:59Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:SKYESkye Bioscience Inc (QB)
05/01/202219:05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SKYESkye Bioscience Inc (QB)
10/11/202114:57Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:SKYESkye Bioscience Inc (QB)
28/09/202114:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:SKYESkye Bioscience Inc (QB)
10/08/202112:04Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:SKYESkye Bioscience Inc (QB)
17/05/202118:24InvestorsHub NewsWireSkye Bioscience's THCVHS Demonstrates Superior Therapeutic Benefit Compared to Glaucoma Standard of Care, both as ...contUSOTC:SKYESkye Bioscience Inc (QB)
13/02/200922:52Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)USOTC:SKYESkye Bioscience Inc (QB)
02/10/200817:08Edgar (US Regulatory)Skyepharma Plc - Prospectus filed pursuant to Rule 424(b)(3) (424B3)USOTC:SKYESkye Bioscience Inc (QB)
11/02/200822:39Edgar (US Regulatory)Skyepharma Plc - Amended Statement of Ownership (SC 13G/A)USOTC:SKYESkye Bioscience Inc (QB)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:SKYE

La tua Cronologia

USOTC
SMSOF
Samsonite International ... (PK)
BIT
UI448X
UniCredit
BIT
IGV
I Grandi Viaggi
BOV
CAON34
Capital One Financial
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network